MSK Biomarker Ctte

Co-chairs: Xiaojuan Li, PhD; Thomas M. Link, MD, PhD
RSNA Staff Support: Susan Stanfa

• Roster

The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK.

Meetings

Approved call summaries:

• January 25, 2022
• November 23, 2021
• September 28, 2021

MSK Biomarker Committee Call Summaries Archive

Profile Documents

• MR-based cartilage compositional biomarkers (T1ρ, T2) for risk prediction, early diagnosis and monitoring of treatment of degenerative joint disease 2021-09-25 - Consensus Profile
• MR-based cartilage compositional biomarkers (T1ρ, T2) for risk prediction, early diagnosis and monitoring of treatment of degenerative joint disease 2020-01-28 - Public Comment Profile